Roberta J. Melander

931 total citations
36 papers, 757 citations indexed

About

Roberta J. Melander is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Roberta J. Melander has authored 36 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in Roberta J. Melander's work include Antibiotic Resistance in Bacteria (16 papers), Bacterial biofilms and quorum sensing (11 papers) and Antimicrobial Peptides and Activities (7 papers). Roberta J. Melander is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Bacterial biofilms and quorum sensing (11 papers) and Antimicrobial Peptides and Activities (7 papers). Roberta J. Melander collaborates with scholars based in United States, Philippines and Uganda. Roberta J. Melander's co-authors include Christian Melander, Daniel V. Zurawski, David F. Ackart, Randall J. Basaraba, David Jung, Brendan K. Podell, Erick A. Lindsey, William T. Barker, Robert K. Ernst and Andrés Obregón‐Henao and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Scientific Reports.

In The Last Decade

Roberta J. Melander

35 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta J. Melander United States 16 345 201 174 144 111 36 757
Roberta J. Melander United States 14 330 1.0× 277 1.4× 124 0.7× 96 0.7× 106 1.0× 31 625
Julieanne M. Bostock United Kingdom 16 409 1.2× 180 0.9× 123 0.7× 133 0.9× 111 1.0× 21 747
Evan Martens United States 7 297 0.9× 173 0.9× 146 0.8× 83 0.6× 111 1.0× 8 730
Steven M. Kwasny United States 10 330 1.0× 312 1.6× 144 0.8× 98 0.7× 76 0.7× 17 685
Soumya Ramu Australia 17 308 0.9× 180 0.9× 183 1.1× 95 0.7× 78 0.7× 19 764
Maxime Gualtiéri France 15 304 0.9× 160 0.8× 109 0.6× 108 0.8× 65 0.6× 25 705
George P. Dinos Greece 18 677 2.0× 181 0.9× 128 0.7× 159 1.1× 97 0.9× 33 1.2k
Timothy R. Kane Canada 5 287 0.8× 255 1.3× 88 0.5× 83 0.6× 71 0.6× 5 797
Shannon B. Falconer Canada 8 343 1.0× 269 1.3× 77 0.4× 131 0.9× 105 0.9× 9 703
Sarah Paulin Switzerland 10 212 0.6× 221 1.1× 94 0.5× 94 0.7× 80 0.7× 11 632

Countries citing papers authored by Roberta J. Melander

Since Specialization
Citations

This map shows the geographic impact of Roberta J. Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta J. Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta J. Melander more than expected).

Fields of papers citing papers by Roberta J. Melander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta J. Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta J. Melander. The network helps show where Roberta J. Melander may publish in the future.

Co-authorship network of co-authors of Roberta J. Melander

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta J. Melander. A scholar is included among the top collaborators of Roberta J. Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta J. Melander. Roberta J. Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stefaniak, Mark H., Vijay Singh Gondil, Mikaeel Young, et al.. (2025). Phenyl urea based adjuvants for β-lactam antibiotics against methicillin resistant Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters. 121. 130164–130164. 1 indexed citations
2.
Koller, Beverly H., et al.. (2024). Adjuvants restore colistin sensitivity in mouse models of highly colistin-resistant isolates, limiting bacterial proliferation and dissemination. Antimicrobial Agents and Chemotherapy. 68(10). e0067124–e0067124. 2 indexed citations
4.
Gondil, Vijay Singh, Mikaeel Young, Roberta J. Melander, et al.. (2024). Development of phenyl‐urea‐based small molecules that target penicillin‐binding protein 4. Chemical Biology & Drug Design. 103(6). e14569–e14569. 1 indexed citations
5.
Harper, Elizabeth I., Tyvette S. Hilliard, Yueying Liu, et al.. (2023). Advanced Glycation End Products as a Potential Target for Restructuring the Ovarian Cancer Microenvironment: A Pilot Study. International Journal of Molecular Sciences. 24(12). 9804–9804. 4 indexed citations
6.
Melander, Roberta J., et al.. (2022). Development of small molecules that work cooperatively with ciprofloxacin to clear salmonella biofilms in a chronic gallbladder carriage model. European Journal of Medicinal Chemistry. 232. 114203–114203. 5 indexed citations
7.
O’Connor, Patrick M., et al.. (2020). A scaffold hopping strategy to generate new aryl-2-amino pyrimidine MRSA biofilm inhibitors. RSC Medicinal Chemistry. 12(2). 293–296. 6 indexed citations
8.
Jeon, Albert B., David F. Ackart, Wei Li, et al.. (2019). 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain. Scientific Reports. 9(1). 1513–1513. 26 indexed citations
9.
Martin, Sara E., Roberta J. Melander, Alison Scott, et al.. (2019). Small Molecule Potentiation of Gram-Positive Selective Antibiotics against Acinetobacter baumannii. ACS Infectious Diseases. 5(7). 1223–1230. 25 indexed citations
10.
Melander, Roberta J., et al.. (2019). Identification of Anti‐Mycobacterial Biofilm Agents Based on the 2‐Aminoimidazole Scaffold. ChemMedChem. 14(9). 927–937. 14 indexed citations
11.
Jung, David, et al.. (2018). New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii. ACS Infectious Diseases. 4(9). 1368–1376. 32 indexed citations
12.
Melander, Roberta J., et al.. (2018). 2-Aminobenzimidazoles as antibiofilm agents against Salmonella enterica serovar Typhimurium. MedChemComm. 9(9). 1547–1552. 9 indexed citations
13.
Melander, Roberta J., Daniel V. Zurawski, & Christian Melander. (2017). Narrow-spectrum antibacterial agents. MedChemComm. 9(1). 12–21. 162 indexed citations
14.
Melander, Roberta J., et al.. (2016). Marine sponge alkaloids as a source of anti-bacterial adjuvants. Bioorganic & Medicinal Chemistry Letters. 26(24). 5863–5866. 26 indexed citations
15.
Podell, Brendan K., et al.. (2015). Second generation 2-aminoimidazole based advanced glycation end product inhibitors and breakers. Bioorganic & Medicinal Chemistry Letters. 25(21). 4820–4823. 13 indexed citations
16.
Podell, Brendan K., et al.. (2015). Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives. Tetrahedron Letters. 56(23). 3406–3409. 10 indexed citations
17.
Ernst, Robert K., et al.. (2015). Potentiation of Francisella resistance to conventional antibiotics through small molecule adjuvants. MedChemComm. 7(1). 128–131. 11 indexed citations
18.
Melander, Roberta J., et al.. (2014). Controlling bacterial behavior with indole-containing natural products and derivatives. Tetrahedron. 70(37). 6363–6372. 113 indexed citations
19.
Melander, Roberta J. & Christian Melander. (2014). Innovative Strategies for Combating Biofilm-Based Infections. Advances in experimental medicine and biology. 831. 69–91. 17 indexed citations
20.
Ackart, David F., Erick A. Lindsey, Brendan K. Podell, et al.. (2014). Reversal ofMycobacterium tuberculosisphenotypic drug resistance by 2-aminoimidazole-based small molecules. Pathogens and Disease. 70(3). 370–378. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026